Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling von Hellinger, Johanna W., Schömel, Franziska, Buse, Judith V., Lenz, Christof, Bauerschmitz, Gerd, Emons, Günter, Gründker, Carsten

Volltext

Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells von Steifensand, Friederike, Gallwas, Julia, Bauerschmitz, Gerd, Gründker, Carsten

Volltext

Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion von Hellinger, Johanna W., Hüchel, Silke, Goetz, Lena, Bauerschmitz, Gerd, Emons, Günter, Gründker, Carsten

Volltext

Single-centre prospective observational study on postdelivery room care von Hartmann, Frederike Vivien, Bauerschmitz, Gerd, Küster, Helmut

Volltext

Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells von Kolb, Katharina, Hellinger, Johanna, Kansy, Maike, Wegwitz, Florian, Bauerschmitz, Gerd, Emons, Günter, Gründker, Carsten

Volltext

Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir von Diaconu, Iulia, Cerullo, Vincenzo, Escutenaire, Sophie, Kanerva, Anna, Bauerschmitz, Gerd J., Hernandez-Alcoceba, Ruben, Pesonen, Sari, Hemminki, Akseli

Volltext

A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model von Hemminki, Akseli, Kanerva, Anna, Kremer, Eric J, Bauerschmitz, Gerd J, Smith, Bruce F, Liu, Bin, Wang, Minghui, Desmond, Renee A, Keriel, Anne, Barnett, Brian, Baker, Henry J, Siegal, Gene P, Curiel, David T

Volltext

Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells von Bauerschmitz, Gerd J, Guse, Kilian, Kanerva, Anna, Menzel, Artur, Herrmann, Isabell, Desmond, Renee A, Yamamoto, Masato, Nettelbeck, Dirk M, Hakkarainen, Tanja, Dall, Peter, Curiel, David T, Hemminki, Akseli

Volltext

Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus von Kanerva, Anna, Zinn, Kurt R, Chaudhuri, Tandra R, Lam, John T, Suzuki, Kaori, Uil, Taco G, Hakkarainen, Tanja, Bauerschmitz, Gerd J, Wang, Minghui, Liu, Bin, Cao, Zhihong, Alvarez, Ronald D, Curiel, David T, Hemminki, Akseli

Volltext

Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses von Kanerva, Anna, Lavilla-Alonso, Sergio, Raki, Mari, Kangasniemi, Lotta, Bauerschmitz, Gerd J, Takayama, Koichi, Ristimäki, Ari, Desmond, Renee A, Hemminki, Akseli

Volltext

Gene Transfer to Ovarian Cancer Versus Normal Tissues with Fiber-Modified Adenoviruses von Kanerva, Anna, Wang, Minghui, Bauerschmitz, Gerd J., Lam, John T., Desmond, Renee A., Bhoola, Snehal M., Barnes, Mack N., Alvarez, Ronald D., Siegal, Gene P., Curiel, David T., Hemminki, Akseli

Volltext

Treatment of ovarian cancer with a tropism modified oncolytic adenovirus von BAUERSCHMITZ, Gerd J, LAM, John T, DALL, Peter, ALEMANY, Ramon, CURIEL, David T, HEMMINKI, Akseli, KANERVA, Anna, SUZUKI, Kaori, NETTELBECK, Dirk M, DMITRIEV, Igor, KRASNYKH, Victor, MIKHEEVA, Galina V, BARNES, Mack N, ALVAREZ, Ronald D

Volltext

Treatment of endometriosis with a VEGF-targeted conditionally replicative adenovirus von Rein, Daniel T., M.D, Schmidt, Torsten, M.D, Bauerschmitz, Gerd, M.D., Ph.D, Hampl, Monika, M.D, Beyer, Ines M., M.D, Paupoo, Arasen A.V., M.D., M.A, Curiel, David T., M.D., Ph.D, Breidenbach, Martina, M.D

Volltext

A Fiber-Modified, Secretory Leukoprotease Inhibitor Promoter-Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer von REIN, Daniel T, BREIDENBACH, Martina, DALL, Peter, HEMMINKI, Akseli, CURIEL, David T, KIRBY, Tyler O, TIE HAN, SIEGAL, Gene P, BAUERSCHMITZ, Gerd J, MINGHUI WANG, NETTELBECK, Dirk M, TSURUTA, Yuko, YAMAMOTO, Masato

Volltext

Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells von Loris, Johanna, Hanesch, Lena, Bauerschmitz, Gerd, Gallwas, Julia, Gründker, Carsten

Volltext

Serotype Chimeric and Fiber-Mutated Adenovirus Ad5/19p-HIT for Targeting Renal Cancer and Untargeting the Liver von DIACONU, Iulia, DENBY, Laura, BAKER, Andrew H, HEMMINKI, Akseli, PESONEN, Sari, CERULLO, Vincenzo, BAUERSCHMITZ, Gerd J, GUSE, Kilian, RAJECKI, Maria, DIAS, Joao D, TAARI, Kimmo, KANERVA, Anna

Volltext

Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells von RUCKRIEGL, SOPHIA, LORIS, JOHANNA, WERT, KATSIARYNA, BAUERSCHMITZ, GERD, GALLWAS, JULIA, GRÜNDKER, CARSTEN

Volltext

Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer von Bauerschmitz, Gerd J., Kanerva, Anna, Wang, Minghui, Herrmann, Isabell, Shaw, Denise R., Strong, Theresa V., Desmond, Renee, Rein, Daniel T., Dall, Peter, Curiel, David T., Hemminki, Akseli

Volltext

Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR61 von BAUERSCHMITZ, GERD, HÜCHEL, SILKE, GALLWAS, JULIA, GRÜNDKER, CARSTEN

Volltext

Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism von Volk, Andrea L., Rivera, Angel A., Kanerva, Anna, Bauerschmitz, Gerd, Dmitriev, Igor, Nettelbeck, Dirk M., Curiel, David T.

Volltext